HBK Sorce Advisory’s Labcorp LH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $253K | Sell |
806
-14
| -2% | -$3.68K | ﹤0.01% | 545 |
|
|
2026
Q1 | $208K | Buy |
820
+34
| +4% | +$9.21K | ﹤0.01% | 600 |
|
|
2025
Q4 | $218K | Sell |
786
-42
| -5% | -$11.2K | 0.01% | 566 |
|
|
2025
Q3 | $234K | Sell |
828
-50
| -6% | -$13.4K | 0.01% | 533 |
|
|
2025
Q2 | $230K | Sell |
878
-15
| -2% | -$3.65K | 0.01% | 521 |
|
|
2025
Q1 | $208K | Sell |
893
-17
| -2% | -$4.13K | 0.01% | 535 |
|
|
2024
Q4 | $209K | Sell |
910
-17
| -2% | -$3.9K | 0.01% | 534 |
|
|
2024
Q3 | $207K | Buy |
+927
| New | +$204K | 0.01% | 538 |
|
|
2024
Q2 | – | Sell |
-919
| Closed | -$201K | – | 596 |
|
|
2024
Q1 | $201K | Sell |
919
-19
| -2% | -$4.18K | 0.01% | 560 |
|
|
2023
Q4 | $213K | Buy |
+938
| New | +$197K | 0.01% | 507 |
|
|
2023
Q3 | – | Sell |
-1,096
| Closed | -$227K | – | 584 |
|
|
2023
Q2 | $227K | Buy |
1,096
+6
| +0.6% | +$1.16K | 0.01% | 511 |
|
|
2023
Q1 | $215K | Sell |
1,090
-1,138
| -51% | -$234K | 0.01% | 521 |
|
|
2022
Q4 | $451K | Buy |
2,228
+631
| +40% | +$123K | 0.01% | 434 |
|
|
2022
Q3 | $281K | Buy |
+1,597
| New | +$327K | 0.02% | 378 |
|
|
2022
Q2 | – | Sell |
-1,576
| Closed | -$357K | – | 518 |
|
|
2022
Q1 | $357K | Sell |
1,576
-6
| -0.4% | -$1.41K | 0.02% | 366 |
|
|
2021
Q4 | $427K | Hold |
1,582
| – | – | 0.02% | 365 |
|
|
2021
Q3 | $382K | Sell |
1,582
-80
| -5% | -$20.2K | 0.02% | 374 |
|
|
2021
Q2 | $394K | Sell |
1,662
-29
| -2% | -$6.61K | 0.02% | 377 |
|
|
2021
Q1 | $371K | Buy |
1,691
+38
| +2% | +$7.63K | 0.02% | 354 |
|
|
2020
Q4 | $289K | Sell |
1,653
-334
| -17% | -$57.7K | 0.02% | 385 |
|
|
2020
Q3 | $321K | Buy |
1,987
+69
| +4% | +$10.9K | 0.02% | 340 |
|
|
2020
Q2 | $274K | Buy |
+1,918
| New | +$265K | 0.02% | 346 |
|
|
2020
Q1 | – | Sell |
-1,696
| Closed | -$246K | – | 429 |
|
|
2019
Q4 | $246K | Buy |
1,696
+224
| +15% | +$32.3K | 0.02% | 373 |
|
|
2019
Q3 | $213K | Buy |
1,472
+20
| +1% | +$2.92K | 0.02% | 383 |
|
|
2019
Q2 | $216K | Buy |
+1,452
| New | +$203K | 0.02% | 377 |
|
|
2018
Q3 | – | Sell |
-1,304
| Closed | -$201K | – | 411 |
|
|
2018
Q2 | $201K | Buy |
+1,304
| New | +$197K | 0.02% | 367 |
|
Other funds holding LH
HBK Sorce Advisory's LH Position: Q2 2026 in Review
HBK Sorce Advisory reduced its Labcorp (LH) stake by 1.7% in Q2 2026, selling an estimated $3.68K and leaving 806 shares worth $253K. The position accounts for ﹤0.01% of the portfolio, ranked #545.
HBK Sorce Advisory first reported a position in LH in Q2 2018 and has held it in 26 quarters since. The position peaked at $451K in Q4 2022. 1,060 funds tracked by Wall St. Rank hold LH as of Q2 2026.
- HBK Sorce Advisory held 806 shares of Labcorp worth $253K as of Q2 2026.
- HBK Sorce Advisory sold 14 Labcorp shares in Q2 2026, an estimated $3.68K.
- Labcorp made up ﹤0.01% of HBK Sorce Advisory's portfolio in Q2 2026, its #545 holding.
- HBK Sorce Advisory first reported a position in Labcorp in Q2 2018 and has held it in 26 quarters since.
- HBK Sorce Advisory's Labcorp position peaked at $451K in Q4 2022.
- 1,060 funds tracked by Wall St. Rank held Labcorp as of Q2 2026.
Based on HBK Sorce Advisory's 13F filing for Q2 2026, filed 6 Aug 2026.